Who owns 881624959 - TEVA PHARMACEUTICAL INDS LTD - PUT based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

TEVA PHARMACEUTICAL INDS LTD - PUT Institutional Ownership

CUSIP 881624959 is the security identifier used in SEC filing datasets for 881624959 - TEVA PHARMACEUTICAL INDS LTD - PUT.

CUSIP: 881624959

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

What is CUSIP 881624959?
CUSIP 881624959 identifies 881624959 - TEVA PHARMACEUTICAL INDS LTD - PUT in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Open recent reporting periods for CUSIP 881624959:

As of 31 Dec 2025, 0 institutional investors reported holding shares of TEVA PHARMACEUTICAL INDS LTD - PUT.

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Price (Median)	Investors
2025 Q4				$74,893,977	$31.21	0
2025 Q3				$61,208,280	$20.20	0
2025 Q2				$43,116,620	$16.76	0
2025 Q1				$38,796,743	$15.37	0
2024 Q4				$85,704,708	$22.04	0
2024 Q3				$59,330,280	$18.02	0
2024 Q2				$47,526,000	$16.25	0
2024 Q1				$62,001,095	$14.11	0
2023 Q4				$64,797,568	$10.44	0
2023 Q3				$56,757,500	$10.20	0
2023 Q2				$40,167,205	$7.53	0
2023 Q1				$54,049,380	$8.85	0
2022 Q4				$79,657,272	$9.12	0
2022 Q3				$79,912,000	$8.07	0
2022 Q2				$96,251,000	$7.52	0
2022 Q1				$80,489,000	$9.39	0
2021 Q4				$78,036,000	$8.01	0
2021 Q3				$49,413,000	$9.83	0
2021 Q2				$44,801,000	$9.90	0
2021 Q1				$33,785,000	$11.54	0
2020 Q4				$75,290,000	$9.65	0
2020 Q3				$65,727,000	$9.01	0
2020 Q2	0	$0	-$214,000	$84,391,000	$12.33	0
2020 Q1	23,900	$214,000	+$214,000	$67,780,000	$8.98	1
2019 Q4				$97,760,000	$9.80	0
2019 Q3				$56,362,000	$6.88	0
2019 Q2	0	$0	-$232,000	$50,253,000	$9.23	0
2019 Q1	14,800	$232,000	+$232,000	$46,710,000	$15.68	1
2018 Q4				$61,254,000	$15.42	0
2018 Q3				$62,502,000	$21.54	0
2018 Q2				$82,245,000	$24.32	0
2018 Q1				$26,018,000	$17.09	0
2017 Q4				$41,717,000	$18.95	0
2017 Q3	0	$0	-$1,909,000	$33,892,000	$17.38	0
2017 Q2	652	$1,909,000		$6,931,000	$266.78	1
2017 Q1	652	$1,995,000		$58,898,000	$32.09	1
2016 Q4	652	$1,734,000	-$5,223,276	$65,584,000	$36.28	1
2016 Q3	2,616	$1,166,000	+$1,166,000	$51,549,000	$46.01	1
2016 Q2				$159,789,000	$50.23	0
2016 Q1				$40,936,000	$53.51	0
2015 Q4				$63,937,000	$65.64	0
2015 Q3				$47,778,000	$56.46	0
2015 Q2				$20,684,000	$59.10	0
2015 Q1				$27,510,000	$62.37	0
2014 Q4				$25,777,000	$76.91	0
2014 Q3				$23,710,000	$53.79	0
2014 Q2				$105,423,000	$66.21	0
2014 Q1				$141,210,000	$52.84	0